Benefit-Risk analyses: Gassman et al. (NEJM) + FDA Dear All: An article by Gassman, Nguyen, and Joffe in today’s NEJM entitled “FDA regulation of prescription drugs” caught my eye because of its emphasis Read More » 16 February 2017 No Comments